CA Patent

CA2638081C — Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions

Assigned to Rockwell Medical Technologies Inc · Expires 2012-07-10 · 14y expired

What this patent protects

A highly water soluble ferric pyrophosphate citrate chelate useful for treating iron deficiency contains 2% or less phosphate by weight. These chelate compositions are easily milled and/or processed into dosage forms using conventional techniques, and are expected to exhibit adva…

USPTO Abstract

A highly water soluble ferric pyrophosphate citrate chelate useful for treating iron deficiency contains 2% or less phosphate by weight. These chelate compositions are easily milled and/or processed into dosage forms using conventional techniques, and are expected to exhibit advantageous biocompatibility as compared to conventional soluble ferric pyrophosphates, ferric salts, ferric polysaccharide complexes and ferrous salts.

Drugs covered by this patent

Patent Metadata

Patent number
CA2638081C
Jurisdiction
CA
Classification
—
Expires
2012-07-10
Drug substance claim
No
Drug product claim
No
Assignee
Rockwell Medical Technologies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.